Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00257894 · ClinicalTrials.gov registry record · Phase 2
Baclofen Effects on Smoking Urge and Withdrawal
A Phase 2 study, sponsored by VA Office of Research and Development.
- Terminated
- Registry status
- Phase 2
- Development phase
- 41
- Enrollment target
NCT00257894: Clinical Trial Phase 2 study, sponsored by VA Office of Research and Development.
NCT00257894 is a Phase 2 study that was terminated before completion, run by VA Office of Research and Development. The registered enrollment target is 41 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00257894, a Phase 2 study, was terminated before completion, sponsored by VA Office of Research and Development.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether baclofen is effective in reducing smoking urge, withdrawal, and reinforcement in moderate to heavy cigarette smokers.
Interventions
- DRUG Placebo
- DRUG Baclofen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00257894
The ClinicalTrials.gov registry entry for NCT00257894 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00257894 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00257894 about?
NCT00257894 is a clinical study titled "Baclofen Effects on Smoking Urge and Withdrawal". The purpose of this study is to determine whether baclofen is effective in reducing smoking urge, withdrawal, and reinforcement in moderate to heavy cigarette smokers.
What is the current status of trial NCT00257894?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 41 participants. The study started on 2005-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00257894?
The interventions under investigation include: Placebo (DRUG), Baclofen (DRUG).
Who is sponsoring clinical trial NCT00257894?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.